Perturbations in neuroinflammatory pathways are associated with paclitaxel-induced peripheral neuropathy in breast cancer survivors
- PMID: 31401418
- PMCID: PMC6788784
- DOI: 10.1016/j.jneuroim.2019.577019
Perturbations in neuroinflammatory pathways are associated with paclitaxel-induced peripheral neuropathy in breast cancer survivors
Abstract
Paclitaxel is a common chemotherapy drug associated with the development of chronic paclitaxel-induced peripheral neuropathy (PIPN). PIPN is associated with neuroinflammatory mechanisms in pre-clinical studies. Here, we evaluated for differential gene expression (DGE) in peripheral blood between breast cancer survivors with and without PIPN and for neuroinflammatory (NI) related signaling pathways and whole-transcriptome profiles from other experiments. Pathway impact analysis identified 8 perturbed NI related pathways. Expression profile analysis found 15 experiments having similar whole-transcriptome profiles of DGE related to neuroinflammation and PIPN. These findings suggest that perturbations in pathways associated with neuroinflammation are found in cancer survivors with PIPN.
Keywords: Breast cancer; Chemokines; Cytokines; Differential gene expression; Neuroinflammation; Neuropathy; Paclitaxel; Pathway analysis; Survivor; Taxanes.
Copyright © 2019 Elsevier B.V. All rights reserved.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures


Similar articles
-
Expression of mitochondrial dysfunction-related genes and pathways in paclitaxel-induced peripheral neuropathy in breast cancer survivors.Mol Pain. 2018 Jan-Dec;14:1744806918816462. doi: 10.1177/1744806918816462. Epub 2018 Nov 14. Mol Pain. 2018. PMID: 30426838 Free PMC article.
-
Phenotypic Characterization of Paclitaxel-Induced Peripheral Neuropathy in Cancer Survivors.J Pain Symptom Manage. 2018 Dec;56(6):908-919.e3. doi: 10.1016/j.jpainsymman.2018.08.017. Epub 2018 Aug 30. J Pain Symptom Manage. 2018. PMID: 30172061 Free PMC article.
-
Estrogen decline is a risk factor for paclitaxel-induced peripheral neuropathy: Clinical evidence supported by a preclinical study.J Pharmacol Sci. 2021 May;146(1):49-57. doi: 10.1016/j.jphs.2021.03.001. Epub 2021 Mar 10. J Pharmacol Sci. 2021. PMID: 33858655
-
Preclinical and Clinical Evidence of Therapeutic Agents for Paclitaxel-Induced Peripheral Neuropathy.Int J Mol Sci. 2021 Aug 13;22(16):8733. doi: 10.3390/ijms22168733. Int J Mol Sci. 2021. PMID: 34445439 Free PMC article. Review.
-
Genetic determinants of paclitaxel-induced peripheral neuropathy: a review of current literature.Drug Metab Rev. 2025 May;57(2):190-207. doi: 10.1080/03602532.2025.2485055. Epub 2025 Mar 31. Drug Metab Rev. 2025. PMID: 40162869 Review.
Cited by
-
Paclitaxel triggers molecular and cellular changes in the choroid plexus.Front Pain Res (Lausanne). 2024 Nov 25;5:1488369. doi: 10.3389/fpain.2024.1488369. eCollection 2024. Front Pain Res (Lausanne). 2024. PMID: 39654799 Free PMC article.
-
A Pilot Study of Associations Between the Occurrence of Palpitations and Cytokine Gene Variations in Women Prior to Breast Cancer Surgery.Biol Res Nurs. 2023 Apr;25(2):289-299. doi: 10.1177/10998004221134684. Epub 2022 Oct 18. Biol Res Nurs. 2023. PMID: 36255356 Free PMC article.
-
Longitudinal study of inflammatory, behavioral, clinical, and psychosocial risk factors for chemotherapy-induced peripheral neuropathy.Breast Cancer Res Treat. 2021 Sep;189(2):521-532. doi: 10.1007/s10549-021-06304-6. Epub 2021 Jun 30. Breast Cancer Res Treat. 2021. PMID: 34191201 Free PMC article.
-
Associations of differentially expressed genes with psychoneurological symptoms in patients with head and neck cancer: A longitudinal study.J Psychosom Res. 2023 Dec;175:111518. doi: 10.1016/j.jpsychores.2023.111518. Epub 2023 Oct 10. J Psychosom Res. 2023. PMID: 37832274 Free PMC article.
-
Differential methylation and expression of genes in the hypoxia-inducible factor 1 signaling pathway are associated with paclitaxel-induced peripheral neuropathy in breast cancer survivors and with preclinical models of chemotherapy-induced neuropathic pain.Mol Pain. 2020 Jan-Dec;16:1744806920936502. doi: 10.1177/1744806920936502. Mol Pain. 2020. PMID: 32586194 Free PMC article.
References
-
- Aoki-Kinoshita K.F., Kanehisa M. Gene annotation and pathway mapping in KEGG. Methods Mol. Biol. (Clifton, NJ) 2007;396:71–91. - PubMed
-
- Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B Methodol. 1995;57:289–300.
-
- Bohn M.J., Babor T.F., Kranzler H.R. The alcohol use disorders identification test (AUDIT): validation of a screening instrument for use in medical settings. J. Stud. Alcohol. 1995;56:423–432. - PubMed